Marksans Pharma Q2 Results
- BSE: 524404
- NSE: MARKSANS
- ISIN: INE750C01026
- Sector: Biotechnology & Drugs
BSE
315.7
7.15 (2.32%)
7.15 (2.32%)Volume83.85 K
Updated: Mon 25 Nov, 2024 | 15:40:44
NSE
315.556.90 (2.24%)
6.90 (2.24%)Volume1.48 M
Updated: Mon 25 Nov, 2024 | 15:44:08
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹641.92 Cr.(8.69%)
- Operating Profit₹116.17 Cr.(7.57%)
- Profit After Tax₹96.72 Cr.(8.97%)
- Operating Margin18.10%(-0.27%)
Note: Comparison is on YoY basis
Quarterly - Marksans Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 641.92 | 500.03 | -% | 531.24 | -% |
| Selling/ General/ Admin Expenses Total | 84.16 | 68.24 | -% | 71.13 | -% |
| Depreciation/ Amortization | 19.51 | 13.66 | -% | 17.55 | -% |
| Other Operating Expenses Total | 163.69 | 87.07 | -% | 93.44 | -% |
| Total Operating Expense | 525.75 | 411.73 | -% | 434.84 | -% |
| Operating Income | 116.17 | 88.31 | -% | 96.40 | -% |
| Net Income Before Taxes | 124.60 | 96.83 | -% | 113.77 | -% |
| Net Income | 96.72 | 68.66 | -% | 83.52 | -% |
| Diluted Normalized EPS | 2.13 | 1.52 | -% | 1.84 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST